Coronary Artery Disease Market Report 2026

Coronary Artery Disease Market Overview

• Coronary Artery Disease market size has reached to $31.88 billion in 2025 • Expected to grow to $53.97 billion in 2030 at a compound annual growth rate (CAGR) of 11.2% • Growth Driver: The Influence Of Rising Coronary Artery Disease Prevalence Fuels The Coronary Artery Disease Market • Market Trend: Pioneer Innovation With Drug-Coated Balloon Catheters In Coronary Artery Disease Market • North America was the largest region in 2025.

What Is Covered Under Coronary Artery Disease Market?

Coronary artery disease (CAD) is a medical condition that affects the coronary arteries, the blood vessels that supply oxygen-rich blood to the heart muscle. Coronary artery disease occurs when arteries become narrowed or blocked due to plaque buildup, a substance composed of cholesterol, fat, calcium, and other substances. The main treatments for coronary artery disease are medication, surgery, additional therapy, and others. Medication refers to substances or drugs that are used to prevent, treat, or manage various medical conditions and diseases, which include clopidogrel, atorvastatin, metoprolol, lisinopril, losartan, amlodipine, nitro-glycerine, other medications. It is diagnosed by electrocardiogram, echocardiogram, stress test, cardiac catheterization, heart CT scan, and others and is distributed by hospital pharmacies, retail pharmacies, online pharmacies, and others. It is used by hospitals, specialty clinics, and others.

What Is The Coronary Artery Disease Market Growth Forecast?

The coronary artery disease market size is expected to see rapid growth in the next few years. It will grow to $53.97 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to aging global population, increasing obesity rates, improved diagnostic technologies, growth of preventive cardiology, rising healthcare access. Major trends in the forecast period include increasing focus on early disease detection, rising use of combination drug therapies, growth of lifestyle modification programs, expansion of minimally invasive treatments, integration of cardiac rehabilitation services.

Global Coronary Artery Disease Market Segmentation

1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments 2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis 3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels 4) By End-User: Hospitals, Specialty Clinics, Other End-Users Subsegments: 1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors 2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery 3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies 4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices

What Is The Driver Of The Coronary Artery Disease Market?

The rise in the prevalence of coronary artery disease is expected to propel the growth of the coronary artery disease market over the coming years. Coronary artery disease (CAD) is a medical condition characterized by the narrowing or blockage of the coronary arteries, which supply blood to the heart muscle. Coronary artery disease cases are increasing due to increased changes in diet, stress, lack of exercise, obesity, age, and others. Coronary artery disease is treated with drugs using clopidogrel, ticagrelor, warfarin, and heparin and with procedures such as coronary artery bypass grafting, angioplasty, and stenting. For instance, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2023, an estimated 2,700 acute coronary events occurred among First Nations people aged 25 and older. When adjusted for population age structure, the rate of these events was 2.8 times greater than that observed in non-Indigenous people.Therefore, the rise in the prevalence of coronary artery disease is expected to boost the coronary artery disease industry during the forecast period.

Key Players In The Global Coronary Artery Disease Market

Major companies operating in the coronary artery disease market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Kowa Pharmaceuticals America Inc., Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V.

Global Coronary Artery Disease Market Trends and Insights

Major companies operating in the coronary artery disease market are focusing on developing innovative products, such as drug-coated balloon catheters, to drive revenues in the market. Drug-coated balloon catheters are medical devices used in interventional cardiology to treat narrowed or blocked blood vessels, particularly in the context of coronary artery disease or peripheral artery disease. For instance, in March 2024, Boston Scientific Corporation, a US-based medical medical device company, announced the US Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue. The AGENT DCB offers a specialized treatment option for the challenging condition of in-stent restenosis (ISR), addressing a significant unmet medical need. It is designed specifically for treating ISR as well as previously untreated small vessel coronary disease. Available in Europe, parts of Asia Pacific, and Latin America, the AGENT DCB provides a targeted solution for these complex cardiovascular conditions.

What Are Latest Mergers And Acquisitions In The Coronary Artery Disease Market?

In April 2023, Abbott Laboratories, a US-based medical devices, and healthcare company, acquired Cardiovascular Systems Inc. for $890 million. This acquisition aims to provide Abbott with a complementary solution for treating vascular disease. Cardiovascular Systems Inc. is a US-based medical device company specializing in developing and commercializing innovative solutions for treating peripheral and coronary artery disease.

Regional Outlook

North America was the largest region in the coronary artery disease market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Coronary Artery Disease Market?

The coronary artery disease market includes revenues earned by entities by providing coronary angioplasty, coronary artery bypass and heart transplant services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Coronary Artery Disease Market Report 2026?

The coronary artery disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the coronary artery disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.